HF 5082

04/07/26   REVISOR  RSI/EN  26-08214
This Document can be made available
in alternative formats upon request  State of Minnesota
  HOUSE OF REPRESENTATIVES
  NINETY-FOURTH SESSION
  H. F. No.   5082
04/27/2026     Authored by Huot; Bierman; Koegel; Lee, X.; Carroll and others
  The bill was read for the first time and referred to the Committee on Commerce Finance and Policy
1.1A bill for an act
1.2relating to health insurance; requiring health plans to provide coverage for cancer
1.3screenings pursuant to American Cancer Society guidelines; amending Minnesota
1.4Statutes 2024, sections 62A.30, subdivision 2; 62Q.50; proposing coding for new
1.5law in Minnesota Statutes, chapter 62Q.
1.6BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:
1.7Section 1. Minnesota Statutes 2024, section 62A.30, subdivision 2, is amended to read:
1.8Subd. 2. Required coverage. (a) Every policy, plan, certificate, or contract referred to
1.9in subdivision 1 that provides coverage to a Minnesota resident must provide coverage for
1.10routine screening procedures for cancer and the office or facility visit, including
1.11mammograms, surveillance tests for ovarian cancer for women who are at risk for ovarian
1.12cancer as defined in subdivision 3, pap smears, and colorectal screening tests for men and
1.13women, when ordered or provided by a physician in accordance with the standard practice
1.14of medicine.
1.15(b) Coverage for colorectal cancer screening must be provided consistent with current
1.16American Cancer Society guidelines. Routine screening procedures include all colorectal
1.17examinations and tests that are administered at a frequency identified in current American
1.18Cancer Society screening guidelines, including but not limited to a follow-up colonoscopy
1.19conducted after a positive noninvasive stool-based screening test, blood test, or direct
1.20visualization test.
1.21(c) Coverage must be provided for all breast cancer screening examinations and tests
1.22that are administered at a frequency identified in current American Cancer Society guidelines
Section 1.  1
04/07/26   REVISOR  RSI/EN  26-08214
2.1  for individuals of average risk and individuals of high risk of developing breast cancer,
2.2  including all breast examinations required by subdivisions 4 and 5.
2.3      (d) A health plan must not impose cost-sharing requirements, including co-pays,
2.4  deductibles, or coinsurance, on the coverage required under this section.
2.5    Sec. 2. Minnesota Statutes 2024, section 62Q.50, is amended to read:
2.6      62Q.50 PROSTATE CANCER SCREENING.
2.7      (a) A health plan must cover prostate cancer screening for men 40 years of age or over
2.8  who are symptomatic or in a high-risk category and for all men 50 years of age or older
2.9  consistent with current American Cancer Society screening guidelines.
2.10     The screening must consist at a minimum of a prostate-specific antigen blood test and
2.11 a digital rectal examination.
2.12     This coverage is subject to any deductible, coinsurance, co-payment, or other limitation
2.13 on coverage applicable to other coverages under the plan.
2.14     (b) The coverage must include all prostate cancer screening examinations and tests that
2.15 are administered at a frequency identified in current American Cancer Society screening
2.16 guidelines, including follow-up examinations. Follow-up examinations include but are not
2.17 limited to urinary analysis, serum biomarker testing, medical imaging, or biopsy.
2.18     (c) A health plan must not impose cost-sharing requirements, including co-pays,
2.19 deductibles, or coinsurance, on the coverage required under this section.
2.20     (d) For purposes of this section, "health plan" includes coverage that is excluded under
2.21 section 62A.011, subdivision 3, clauses (7) and (10).
2.22   Sec. 3. [62Q.501] CERVICAL CANCER SCREENING.
2.23     (a) A health plan must cover cervical cancer screening for women consistent with current
2.24 American Cancer Society screening guidelines.
2.25     (b) The coverage must include all cervical cancer screening examinations and tests that
2.26 are administered at a frequency identified in current American Cancer Society screening
2.27 guidelines, including follow-up examinations used to evaluate an abnormality seen or
2.28 suspected from a cervical cancer screening, regardless of whether different samples from
2.29 the prior cervical cancer screening are used or the follow-up examination is performed on
2.30 a different date than the cervical cancer screening. Follow-up examinations include but are
Sec. 3.  2
04/07/26   REVISOR  RSI/EN  26-08214
3.1  not limited to human papillomavirus examinations with typing, cytology, dual stain, or
3.2  colposcopy with biopsy.
3.3      (c) A health plan must not impose cost-sharing requirements, including co-pays,
3.4  deductibles, or coinsurance, on the coverage required under this section.
3.5    Sec. 4. [62Q.502] LUNG CANCER SCREENING.
3.6      (a) A health plan must cover lung cancer screening consistent with current American
3.7  Cancer Society screening guidelines.
3.8      (b) The coverage must include all lung cancer screening examinations and tests that are
3.9  administered at a frequency identified in current American Cancer Society screening
3.10 guidelines, including follow-up examinations. Follow-up examinations include but are not
3.11 limited to chest x-ray, computed tomography scan, magnetic resonance imaging, positron
3.12 emission tomography scan, or biopsy.
3.13     (c) A health plan must not impose cost-sharing requirements, including co-pays,
3.14 deductibles, or coinsurance, on the coverage required under this section.
3.15   Sec. 5. EFFECTIVE DATE.
3.16     Sections 1 to 4 are effective January 1, 2027, and apply to health plans offered, issued,
3.17 or renewed on or after that date.
Sec. 5.  3